4
Changes in Ownership
GT Biopharma, Inc. Filed Acc 0001181431-03-027473
Options or other derivatives
- Director acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| WEBB TED FORD Director | 2003-09-30 | Grant or award · Stock Option (right to buy) | −30,000 | $0.38 | $11,400 | 30,000 | D: show line 1 in the form |
Loading xslF345X02/rrd20897.xml…